T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease

Leuk Lymphoma. 1999 Apr;33(3-4):393-8. doi: 10.3109/10428199909058442.

Abstract

We report on a patient with recurrent T-cell-rich B-cell lymphoma (TCRBCL), initially misdiagnosed as a lymphocyte-rich Hodgkin's disease. This case exemplifies the diagnostic problems of TCRBCL and the need for immunophenotypic analysis to differentiate TCRBCL from Hodgkin's disease, nodular paragranuloma and peripheral T-cell lymphoma. A rather unusual aspect is the long disease-free interval between the excision of the node in and the late relapse in 1996. The significance of the abundant T-cell infiltration in this B-cell neoplasm will be discussed and the concepts concerning antitumor response will be reviewed. Based on epidemiological data and the clinical behaviour TCRBCL does not seem to represent a distinctive pathological entity.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antigens, CD / analysis
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Diagnosis, Differential
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • Immunophenotyping
  • Lymph Nodes / immunology
  • Lymph Nodes / pathology
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / immunology*
  • Lymphoma, B-Cell / pathology*
  • Lymphoma, T-Cell / pathology
  • Male
  • Neoplasm Staging
  • Recurrence
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology*
  • Vincristine / administration & dosage

Substances

  • Antigens, CD
  • Bleomycin
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide

Supplementary concepts

  • VAPEC-B protocol